Newsroom

$2.4 M grant to help researchers develop gene and cell therapies for a leading cause of blindness
September 15, 2021 - A team led by Dr. Catherine Tsilfidis has received $2.4 M from the Ontario Research Fund to develop treatments for retinal diseases, a leading cause of blindness.
Translational Research Grant could spark new approaches to diagnose, treat long COVID
September 15, 2021 - Recent studies suggest that more than half of people with COVID-19 will continue to experience symptoms several weeks after infection.
Biomanufacturing partnership boosts Canada’s life-saving treatment and vaccine capacity
September 13, 2021 - As Canada seeks to rebuild its biomanufacturing sector and support made-in-Canada solutions to global health challenges, The Ottawa Hospital, the University of Alberta and BioCanRx have collaborated to create Canada’s first full-service, ...
Outpatient clinic linked to 40% decrease in return ED visits for cellulitis
September 8, 2021 - Cellulitis, a common bacterial skin infection, accounts for 3% of all ED visits. Patients with severe cases that need intravenous (IV) antibiotics are normally admitted to hospital or must return to the ED several times to receive the multiple ...
Could a drug that controls appetite also treat schizophrenia and Alzheimer’s? Mouse studies show promise.
September 8, 2021 - Two recent studies suggest that the drug trodusquemine has the potential to treat symptoms of both schizophrenia and Alzheimer’s disease. This is because the drug targets an enzyme called PTP1B, which plays a role in both diseases
See all news items | See only press releases
Media contacts

Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
613-798-5555 x 73687
ambuchanan@ohri.ca

Jennifer Ganton
Director, Communications and Public Relations,
Ottawa Hospital Research Institute
613-737-8899 x 73325
jganton@ohri.ca

Ottawa Hospital Facebook linkOttawa Hospital Twitter linkOttawa Hospital YouTube link

Media resources
OHRI Fact Sheet
OHRI Annual Report